Shengnuo Biotechnology released its half-year report for 2024, achieving revenue of RMB 0.199 billion, a YoY increase of 14.44%. The net income attributable to shareholders of the listed company was RMB 21.7876 million, an increase of 8.14% YoY.
圣诺生物：半年度净利润2178.76万元 同比增长8.14%
Shengnuo Biotechnology: Net income for the first half year was RMB 21.7876 million, an increase of 8.14% YoY.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.